Browsing by Author Balloch A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Publication DateTitleAuthor(s)TypeSubject
24-May-202010-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial.Oguoma VM; Wilson N; Mulholland K; Santosham M; Torzillo P; McIntyre P; Smith-Vaughan H; Balloch A; Chatfield M; Lehmann D; Binks MJ; Chang A; Carapetis JR; Krause VL; Andrews RM; Snelling T; Licciardi P; Morris PS; Leach AJJournal Article- Request Copy
 
25-Dec-2018Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia.Binks MJ; Moberley SA; Balloch A; Leach AJ; Nelson S; Hare KM; Wilson C; Nelson J; Morris PS; Ware RS; Tang MLK; Torzillo PJ; Carapetis JR; Mulholland K; Andrews RMJournal Article23-valent pneumococcal polysaccharide vaccine; Acute lower respiratory infection; Australia; Indigenous; Pregnancy Request Copy
 
16-Jan-2015Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial.Leach AJ; Mulholland EK; Santosham M; Torzillo PJ; Brown NJ; McIntyre P; Smith-Vaughan H; Skull S; Balloch A; Andrews RM; Carapetis J; McDonnell J; Krause VL; Morris PSComparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov'tIMMUNOLOGY; MICROBIOLOGY; PUBLIC HEALTH Request Copy